Sheldon L. Kaplan

1 month ago | digitalcommons.library.tmc.edu | Amanda Macias |Grant Stimes |Sheldon L. Kaplan |Jesús Vallejo

Background: Clindamycin resistance among community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) complicates the management of a challenging infection. Little data exist to guide clinicians in the management of invasive clindamycin-resistant CA-MRSA infections in children and studies using oral regimens such as trimethoprim-sulfamethoxazole (TMP-SMX) and linezolid for treatment of these infections are limited.

Jan 20, 2025 | mdpi.com | Amanda Macias |Sheldon L. Kaplan |Jesús Vallejo |Grant Stimes

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Apr 12, 2023 | mdpi.com | Susanna Esposito |Francesco Blasi |Nigel Curtis |Sheldon L. Kaplan

Abstract:Staphylococcus aureus is an extremely virulent pathogen that is capable of quickly evolving and developing antibiotic resistance. To overcome this problem, new antibiotics have been developed.